Competitive Binding Assays at Y2-R Peptide binding to the human Y2-R was measured in a dose-responsive manner (1 pM 1 M) using a radioligand competitive binding assay in CHO-K1 cells
These include: Neurological symptoms : tingling or numbness in hands and feet (peripheral neuropathy), difficulty walking or balance problems, memory difficulties, or mood changes including depression Haematological signs : persistent fatigue, weakness, pale or jaundiced skin, or shortness of breath Glossitis : a sore, red, smooth tongue Cognitive symptoms : difficulty concentrating, confusion, or "brain fog" Seek urgent medical attention if you experience rapidly worsening neurological symptoms, significant difficulty walking, severe paraesthesia, or marked cognitive decline, as these may require immediate assessment
Why take that gamble when there are established, well-researched options available
Neonatology/Paediatrics-Guidelines on Parenteral Nutrition, Chapter 13
